Ultrasound could help doctors manage fluids during kidney treatment
NCT ID NCT06254703
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 100 critically ill adults with severe kidney failure who were receiving continuous kidney replacement therapy. Researchers used a special ultrasound technique to check for fluid buildup in the body, which can harm organs. The goal was to see how common fluid congestion is and whether ultrasound can help guide treatment and improve recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
100 people
The number who actually took part.
- Started
-
Mar 2024
- Finished
-
Nov 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients without ESRD that initiate CKRT
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adults (≥ 18 years of age) 2. Admitted to ICU 3. Plan to initiate CKRT by clinician's judgement Exclusion Criteria: 1. Refuse to participate 2. Previous diagnosis of end-stage kidney disease (ESKD) currently on kidney replacement therapy 3. Kidney tran splant recipient 4. Receive KRT before ICU admission 5. Structural kidney diseases which will interfere with intrarenal doppler ultrasound e.g. renal artery stenosis, autosomal dominant polycystic kidney disease etc. 6. Patients with previously known conditions that interfere with portal doppler assessment, namely liver cirrhosis, severe tricuspid regurgitation with structural heart disease or massive ascites. 7. Underlying disease process with a life expectancy less than 90 days 8. Pregnancy 9. Concomitant severe respiratory distress syndrome 10. Expected life expectancy \<48 hours 11. Receiving extracorporeal membrane oxygenation (ECMO)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute kidney failure stage 3 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
King chula memorial hospital
Bangkok, Bangkok, 10330, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.